Capricor Therapeutics to Present on Exosomes as a Basis for Innovative Platform Technology at 11th International Symposium on Stem Cell Therapy and Cardiovascular Innovations
May 28, 2014 14:36 ET
|
Capricor Therapeutics, Inc.
Identifies Exosomes Originating From Cardiosphere-Derived Cells (CDCs) as Key Mediators of Myocardial Regeneration
Highlights Potential Utility of Exosomes as Cell-Free Therapeutic Candidate
LOS...
Capricor Therapeutics Reports First Quarter 2014 Business Highlights
May 15, 2014 16:10 ET
|
Capricor Therapeutics, Inc.
Signs Collaboration Agreement With Janssen Biotech;
Initiates Phase II Clinical Study of CAP-1002
Conference Call Scheduled for Thursday May 15, 2014 at 4:30 p.m. Eastern Time
LOS ANGELES, May...
Capricor Therapeutics to Hold First Quarter 2014 Business Update Conference Call on May 15, 2014 at 4:30 p.m. Eastern Time
May 14, 2014 08:30 ET
|
Capricor Therapeutics, Inc.
LOS ANGELES, May 14, 2014 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company focused on developing novel therapeutics to prevent and treat heart disease, today...
Capricor Therapeutics Enters Into Exclusive License With Cedars-Sinai Medical Center for Exosome-Related IP Portfolio
May 06, 2014 13:31 ET
|
Capricor Therapeutics, Inc.
LOS ANGELES, May 6, 2014 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases,...
Capricor Therapeutics to Present ALLSTAR Phase I Trial Data at ACC Annual Meeting 2014
March 28, 2014 13:41 ET
|
Capricor Therapeutics, Inc.
LOS ANGELES, March 28, 2014 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company focused on developing novel therapeutics to prevent and treat heart disease, today...
Capricor Therapeutics to Present at Two Upcoming Investor Conferences
March 10, 2014 14:10 ET
|
Capricor Therapeutics, Inc.
LOS ANGELES, March 10, 2014 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (OTCBB:CAPR) today announced that Chief Executive Officer Dr. Linda Marbán is scheduled to present at the 26th Annual...
Capricor Therapeutics and Janssen Biotech, Inc. Enter Into Collaboration Agreement and Exclusive License Option
January 06, 2014 08:30 ET
|
Capricor Therapeutics, Inc.
LOS ANGELES, Jan. 6, 2014 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (OTCBB:CAPR) today announced that it has executed a collaboration agreement and exclusive license option with Janssen Biotech,...